From: Risk communication in clinical trials: A cognitive experiment and a survey
Variable | Category/statistics | All participants | Frequency group | Percentage group | Descriptors group | P* |
---|---|---|---|---|---|---|
Age (years) | Mean (SD) | 51.5 (12.6) | 52.3 (11.1) | 51.6 (13.2) | 50.6 (13.6) | 0.694 |
Gender | Female | 140 (58.3%) | 35 (42.7%) | 32 (40.0%) | 33 (42.3%) | 0.945 |
 | Male | 100 (41.7%) | 47 (57.3%) | 48 (60.0%) | 45 (57.7%) |  |
Education | Primary or below | 29 (12.1%) | 12 (14.6%) | 10 (12.5%) | 7 (9.1%) | 0.673 |
 | Secondary or Diploma | 154 (64.2%) | 53 (64.6%) | 48 (60.0%) | 53 (68.8%) |  |
 | Graduate or Postgraduate | 56 (23.3%) | 17 (20.7%) | 22 (27.5%) | 17 (22.1%) |  |
Marital status | Married | 51 (21.3%) | 18 (22.0%) | 16 (20.0%) | 17 (21.8%) | 0.947 |
 | Single | 183 (76.3%) | 61 (74.4%) | 62 (77.5%) | 60 (76.9%) |  |
 | Divorce/Separated | 6 (2.5%) | 3 (3.7%) | 2 (2.5%) | 1 (1.3%) |  |
Ethnicity | Chinese | 188 (78.3%) | 64 (78.1%) | 66 (82.5%) | 58 (74.4%) | 0.901 |
 | Malay | 21 (8.8%) | 8 (9.8%) | 5 (6.3%) | 8 (10.3%) |  |
 | Indian | 16 (6.7%) | 6 (7.3%) | 4 (5.0%) | 6 (7.7%) |  |
 | Others | 15 (6.3%) | 4 (4.9%) | 5 (6.3%) | 6 (7.7%) |  |
Disease type | Arthritis | 78 (32.5%) | 28 (34.2%) | 26 (32.5%) | 24 (30.8%) | 0.831 |
 | Breast cancer | 49 (20.4%) | 17 (20.7%) | 16 (20.0%) | 16 (20.5%) |  |
 | Colorectal cancer | 25 (10.4%) | 9 (11.0%) | 7 (8.8%) | 9 (11.5%) |  |
 | Gynaecological cancer | 13 (5.4%) | 4 (4.9%) | 7 (8.8%) | 2 (2.6%) |  |
 | Head and neck cancer | 17 (7.1%) | 5 (6.1%) | 6 (7.5%) | 6 (7.7%) |  |
 | Lung cancer | 18 (7.5%) | 9 (11.0%) | 5 (6.3%) | 4 (5.1%) |  |
 | Other cancers | 40(16.7%) | 10 (12.2%) | 13 (16.3%) | 17 (21.8%) |  |